-

Another Giant Stride: ACCELQ Health & Life Science's Vertical Posts Massive Growth Numbers

ACCELQ expanded its healthcare presence by a staggering 175%, enabling organizations globally to achieve Continuous Testing

DALLAS--(BUSINESS WIRE)--ACCELQ’s AI-powered no-code test automation platform forges ahead into the expanded realm of health care and pharmaceuticals. The development unfolds after successful implementations of test automation for leading health care enterprises, bringing many business benefits to the table. Each of these projects have stood out in terms of reduced hours of automated regression testing, implementing re-usable business workflows embracing easy automation of newer business processes to name a few.

ACCELQ constantly endeavors to reinvent its AI codeless continuous testing platform making itself agile while aligning itself to various unique business and market demands. This leap into the health care services and life sciences domain comes as no surprise after joining hands with renown names in the industry. ACCELQ has catered to the diverse testing requirements of the application stack of health care behemoths. This list includes biotechnology and pharmaceutical manufacturers like Pfizer, medical device manufacturers like Boston Scientific, health care and well-being firms like UnitedHealth Group, etc.

Senior QE Manager from UnitedHealth Group adds “Our journey with ACCELQ has brought significant maturity to our Test Automation objectives and alignment with CI/CD to enable faster releases at higher quality while keeping costs in check. ACCELQ's ability to handle our complex tech stack while staying true to its No-Code approach has made the difference in helping us scale up Automation across our app portfolio.”

Guljeet Nagpaul, Chief of product and strategy at ACCELQ enthusiastically adds: “Our expansion and specialization in the Health and Life Sciences vertical has been instrumental. The depth of the ACCELQ platform, coupled with solution alignment, is powering the largest healthcare organization globally to speed up Quality and achieve significant efficiency in their DevOps process.”

ACCELQ is ISO 27001, SOC 1 and SOC2 certified, ensures utmost security of sensitive data, protected health information and complies with all health care security standards and mandated data protection regulations.

Contacts

Media contact:
Geosley Andrades
415-941-3610
marketing@accelq.com
14241 Dallas Parkway, Suite 520
Dallas, Texas 75254
United States

ACCELQ


Release Summary
ACCELQ’s AI-powered no-code test automation platform forges ahead into the expanded realm of health care and pharmaceuticals.
Release Versions

Contacts

Media contact:
Geosley Andrades
415-941-3610
marketing@accelq.com
14241 Dallas Parkway, Suite 520
Dallas, Texas 75254
United States

Social Media Profiles
More News From ACCELQ

ACCELQ Autopilot Named “AI-based Engineering Solution of the Year” in 2025 Artificial Intelligence Breakthrough Awards Program

DALLAS--(BUSINESS WIRE)--ACCELQ today announced that it has been awarded “AI-based Engineering Solution of the Year” in the 8th annual AI Breakthrough Awards program....

ACCELQ's Gen AI Offering Sets Itself Apart

DALLAS--(BUSINESS WIRE)--ACCELQ, a leader in AI-powered test automation for enterprise applications, today unveiled significant enhancements to its Autopilot offering....

ACCELQ Expands Into the South African Sub-Continent With Key Customer Wins and Strong Channel Partners.

JOHANNESBURG--(BUSINESS WIRE)--ACCELQ is steadily expanding into Republic of South Africa, gearing up to embrace all growth opportunities in the offing....
Back to Newsroom